| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | RVI BIOTECNOLOGÍA | 29,82% | 38,02% | -13,29% | · |
| TEMPLETON EMERGING MARKETS W (YDIS) EUR-H1 | RVI EMERGENTES | 29,82% | 89,78% | 33,10% | · |
| FIDELITY FUNDS-EMERGING MARKETS I-DIST-GBP | RVI EMERGENTES | 29,81% | 70,13% | 21,36% | 103,27% |
| DWS INVEST CROCI GLOBAL DIVIDENDS GBP IC | RVI GLOBAL | 29,80% | 37,99% | 66,77% | · |
| IMGP JAPAN OPPORTUNITIES N EUR HP | RVI JAPÓN | 29,80% | 86,57% | 141,30% | 214,18% |
| SCHRODER ISF ASIAN DIVIDEND MAXIMISER A ACC EUR | RVI ASIA EX-JAPÓN VALOR | 29,80% | 61,31% | 63,23% | 113,97% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP EUR | RVI BIOTECNOLOGÍA | 29,79% | 68,61% | 70,62% | 200,51% |
| CANDRIAM EQUITIES L ONCOLOGY N CAP EUR | RVI SALUD | 29,79% | 33,47% | · | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 29,79% | 49,51% | -15,55% | · |
| MSIF SUSTAINABLE EMERGING MARKETS EQUITY Z (USD) | RVI EMERGENTES | 29,79% | 80,89% | 49,77% | · |
